Nail PsoriasisNCT05695833
Nd:YAG Laser and Radiofrequency in Treatment of Fingernail Psoriasis
A study testing Radiofrequency in people with Nail Psoriasis, run by Cairo University.
Trial summary
Compare the effect of Radiofrequency to long pulsed Nd:YAG 1064 nm laser in treatment of fingernail psoriasis. Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Nail Psoriasis
- What is being tested?
- Radiofrequency
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- No sites listed yet
- Study dates
- 20 Jan 2023to 20 May 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Nail Psoriasis
Who cannot join
- Manual workers
About this study
Official title: Comparative Study Between Long Pulsed Nd:YAG Laser and Radiofrequency in Treatment of Fingernail Psoriasis
Compare the effect of Radiofrequency to long pulsed Nd:YAG 1064 nm laser in treatment of fingernail psoriasis.
- Conditions
- Nail Psoriasis
- Being tested
- Radiofrequency
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
RadiofrequencyDevice
Device emitting electric waves generating heat
| Study group | Role | What they receive |
|---|---|---|
| Radiofrequency | Experimental | Device Receives: Device: Radiofrequency |
| Nd Yag Laser | Active comparator | Device Receives: Device: Radiofrequency |
What is being measured
The primary outcome is the main question the study is designed to answer.
Targeted Nail Psoriasis Severity Index (tNAPSI) score
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Jan 2023
- Study start20 Jan 2023 (estimated)
- Primary completion20 Apr 2023 (estimated)
- Study completion20 May 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Nail PsoriasisStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hagar El Sayed, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05695833
- Sponsor's protocol ID
- Radiofrequency nail psoriasis
- Status last verified
- Jan 2023
- First submitted
- 13 Jan 2023
- Last updated
- 25 Jan 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
El-Basiony MAS, El-Komy MHM, Samy NA, Aly DG, El-Gendy H, Soliman MM, Abdel Salam Hassan MF, El Sayed H. Efficacy of Nonablative Bipolar Radiofrequency in the Treatment of Fingernail Psoriasis. Dermatol Surg. 2025 May 1;51(5):522-526. doi: 10.1097/DSS.0000000000004531. Epub 2024 Dec 16.
PubMed 39679566
Study at a glance
From the registry record, last updated by the sponsor on 25 Jan 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparative Study Between Long Pulsed Nd:YAG Laser and Radiofrequency in Treatment of Fingernail Psoriasis
- ClinicalTrials.gov ID
- NCT05695833
- Acronym / sponsor ID
- Radiofrequency nail psoriasis
- Conditions
- Nail Psoriasis
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 20 Jan 2023 (estimated)
- Primary completion
- 20 Apr 2023 (estimated)
- Study completion
- 20 May 2023 (estimated)
- First posted
- 25 Jan 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Compare the effect of Radiofrequency to long pulsed Nd:YAG 1064 nm laser in treatment of fingernail psoriasis.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Radiofrequency | Experimental | Device: RadiofrequencyDevice |
| Nd Yag Laser | Active comparator | Device: RadiofrequencyDevice |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Nail Psoriasis
Key exclusion criteria (1 listed)
- Manual workers
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| RadiofrequencyDevice emitting electric waves generating heat | Device | Nd Yag Laser, Radiofrequency |
Primary outcome
Targeted Nail Psoriasis Severity Index (tNAPSI) score
Time frame: 12 weeks
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Jan 2023.
- Derived from this study: PubMed 39679566El-Basiony MAS, El-Komy MHM, Samy NA, Aly DG, El-Gendy H, Soliman MM, Abdel Salam Hassan MF, El Sayed H. Efficacy of Nonablative Bipolar Radiofrequency in the Treatment of Fingernail Psoriasis. Dermatol Surg. 2025 May 1;51(5):522-526. doi: 10.1097/DSS.0000000000004531. Epub 2024 Dec 16.
Related trials for Nail Psoriasis
Not yet recruiting
Efficacy of Fractional Co2 Laser With Topical Tacrolimus 0.1 in the Treatment of Nail Psoriasis
Nail Psoriasis
RecruitingPhase 4
An Open Label Trial to Evaluate Efficacy and Safety of Roflumilast 0.3% Cream for Chronic Plaque and Nail Psoriasis
Chronic Plaque Psoriasis, Nail Psoriasis
Active, not recruitingPhase 2
Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study
Nail Psoriasis
Recruiting
Clinical Study on the Medical Device PROXERA PSOMED 30 for the Treatment of Nail Psoriasis: Evaluation of Safety and Efficacy
Nail Psoriasis
Active, not recruitingObservational study
Psorcast Mobile Study
Psoriatic Arthritis, Psoriasis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Radiofrequency in people with Nail Psoriasis, run by Cairo University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 25 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Targeted Nail Psoriasis Severity Index (tNAPSI) score (time frame: 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05695833, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jan 2023.